A model for evaluating the economic value of prevention programs for illicit use of anabolic androgenic steroids [Elektronisk resurs]
-
Sampaio, Filipa, 1985- (författare)
-
Ssegonja, Richard (författare)
-
Thiblin, Ingemar (författare)
-
Nystrand, Camilla (författare)
-
Uppsala universitet Medicinska och farmaceutiska vetenskapsområdet (utgivare)
-
Uppsala universitet Medicinska och farmaceutiska vetenskapsområdet (utgivare)
- Publicerad: ELSEVIER IRELAND LTD, 2021
- Engelska.
-
Ingår i: Health Policy. - 0168-8510. ; 125:6, 807-813
-
Läs hela texten
-
Läs hela texten
-
Läs hela texten
Sammanfattning
Ämnesord
Stäng
- Background: The illicit use of anabolic androgenic steroids (AAS) has become a societal concern. We developed a decision-analytic model for assessing the cost-effectiveness of preventive interventions targeting AAS-use. We used scenario analyses to demonstrate: a) the potential health economic consequences of AAS use in Sweden, and b) the cost-effectiveness of a hypothetical preventive intervention. Methods: A population-based cohort model compared a hypothetical preventive intervention targeting AAS with a 'no intervention' scenario, from a limited societal perspective. The model simulated how a cohort of 18 year-old males transitioned between different states and predicted their health status and complications until the age of 41. Health outcomes were estimated as quality-adjusted life-years (QALY). Costs included intervention costs, drug costs, and costs of complications. Results: Total yearly costs related to AAS use amounted to nearly half a million US$, with the largest cost borne by the healthcare sector. Results suggest that AAS prevention could entail large costs and benefits with a mean incremental cost-effectiveness ratio of $550 per QALY, in a scenario where the intervention would decrease the probability of initiating AAS use by 5%. Conclusion: Results show large AAS related costs, and suggest that the implementation of a preventive intervention could offer good value for money given different effectiveness scenarios. This model can be used to estimate the value of interventions targeting AAS use.
Ämnesord
- Medical and Health Sciences (hsv)
- Health Sciences (hsv)
- Health Care Service and Management, Health Policy and Services and Health Economy (hsv)
- Medicin och hälsovetenskap (hsv)
- Hälsovetenskaper (hsv)
- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv)
Genre
- government publication (marcgt)
Indexterm och SAB-rubrik
- Anabolic steroids
- Cost-effectiveness
- Economic evaluation
- Prevention
Inställningar
Hjälp
Ingår i annan publikation. Gå till titeln
Health Policy